✦ LIBER ✦

Follow-up Study of Patients Diagnosed with Chronic Myelogenous Leukemia Treated with STI 571 in Ecuador

✍ Scribed by César Paz-y-Miño; Melissa Arévalo; María Eugenia Sánchez; Claudio Cañizares; Paola E. Leone

Book ID: 113467054
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 38
Category: Article
ISSN: 0188-4409
DOI: 10.1016/j.arcmed.2006.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central Nervous System Failure in Patien

Central Nervous System Failure in Patients with Chronic Myelogenous Leukemia Lymphoid Blast Crisis and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Treated with Imatinib (STI-571)

✍ Leis, Jose F; Stepan, Daniel E; Curtin, Peter T; Ford, John M; Peng, Bin; Schuba 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 198 KB

Efficacy of imatinib mesylate (STI571) t

Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia

✍ K. Miyachi; A. Ihara; R. W. Hankins; R. Murai; S. Maehiro; H. Miyashita 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 248 KB

The effects of STI571 on antigen present

The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia

✍ Naoko Sato; Miwako Narita; Masuhiro Takahashi; Kumiko Yagisawa; Aichun Liu; Taka 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

## Abstract Chronic myelogenous leukemia is caused by the acquisition of the reciprocal (9;22)(q34;q11) chromosomal translocation in hematopoietic stem cells. The fusion protein showed higher and aberrant tyrosine kinase activity. The inhibition of the tyrosine kinase activity of the protein repres

Exacerbation of psoriasis in a chronic m

Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib

✍ Seung Man WOO; Chang Hun HUH; Kyung Chan PARK; Sang Woong YOUN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB

Long-term follow-up results of alpha-int

Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia

✍ Sacchi, S; Kantarjian, H M; O’Brien, S; Beran, M; Koller, C; Pierce, S; Kornblau 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 224 KB

Unexpected occurrence of second malignan

Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia

✍ Roy, L; Guilhot, J; Martineau, G; Larchée, R; Guilhot, F 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB